Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2007
11/15/2007CA2650904A1 Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents
11/14/2007EP1854884A2 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
11/14/2007EP1854795A1 Salt of proline derivative, solvate thereof, and production method thereof
11/14/2007EP1854784A1 Activator for peroxisome proliferator activating receptor
11/14/2007EP1854485A1 Preventives/remedies for cancer
11/14/2007EP1854464A2 Combinations comprising epothilone derivatives
11/14/2007EP1853315A1 Treatment for mucositis
11/14/2007EP1853262A1 Pharmaceutical composition comprising amorphous rosiglitazone
11/14/2007EP1687006B1 Pharmaceutical compositions for the treatment of renal dysfunction
11/14/2007EP1581223B1 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
11/14/2007EP1565212B1 Gastrin compositions and formulations, and methods of use and preparation
11/14/2007EP1509537B9 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/14/2007EP1495018B1 Tricyclic thrombin receptor antagonists
11/14/2007EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007EP1423012B1 Medical use of stem cells expressing vegfr-1
11/14/2007EP1411064B1 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
11/14/2007EP1387698B1 Method of preventing cell death using antibodies to neural thread proteins
11/14/2007EP1370264B1 Nicotinic receptor agonists for the treatment of pulmonary inflammatory diseases
11/14/2007EP1362053B1 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/14/2007EP1235592B1 Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicament
11/14/2007EP1210462B1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications
11/14/2007EP1181042B1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
11/14/2007EP1091735B1 Improved enriched platelet wound healant
11/14/2007EP0641218B2 Use of angiotensin antagonist (at1) for reducing post myocardial infarct mobidity and mortality
11/14/2007CN101072815A Polymeric polphenol extracted for fermented tea, therapeutic agent for mitochondrial disease, preventive/therapeutic agent for diabetes mellitus, and food or beverage
11/14/2007CN101072783A Phosphonic acid derivative and therapeutic agent for disease in which high phosphate level in blood participates
11/14/2007CN101070344A G-csf receptor agonist antibodies and screening method therefor
11/14/2007CN101070316A Di-aryl acid derivatives as ppar receptor ligands
11/14/2007CN101069699A Bone-tonifying pills for promoting bone growth
11/14/2007CN101069685A Solid drug for oral use
11/14/2007CN101069684A Composition comprising a cholesterol absorption inhibitor, and hmg-coa reductase inhibitor and a stabilizing agent
11/14/2007CN101069546A Poria-cocos eight-treasures noodles and preparing method
11/14/2007CN100348611C Method for producing soybean trypsin inhibitor concentration
11/14/2007CN100348609C Glucocorticoid receptor ligands for the treatment of metabolic disorders
11/14/2007CN100348600C Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of growth hormone release inhibiting factor receptors
11/14/2007CN100348598C Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
11/14/2007CN100348587C Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/14/2007CN100348584C 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
11/14/2007CN100348580C Taxol enhancer compounds
11/14/2007CN100348569C Induction of apoptosis in cancer cells
11/14/2007CN100348266C Peptide antagonists of zonulin and methods for use of the same
11/14/2007CN100348265C Controlled release composition and method of producing the same
11/14/2007CN100348237C Chinese medicine for improving memory and its preparation method
11/13/2007US7294720 N3-(hydroxy- or alkoxyphenyl) amidrazone, e.g., N3-[3-Methoxyphenyl]-p-tert-butyl-benzamidrazone, are intermediates for preparing phenyl-1,2,4-triazoles, e.g., 1-{3-[4-(tert-Butyl)phenyl]-(1,2,4-triazol-4-yl)}-3-methoxybenzene
11/13/2007US7294652 Autoimmune conditions and NADPH oxidase defects
11/13/2007US7294648 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof
11/13/2007US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007US7294634 Controlling cell proliferation; anticancer agents
11/13/2007US7294633 Oxazolo-and furopyrimidines and their use in medicaments against tumors
11/13/2007US7294629 Drugs as enzyme inhibitors for tyrosine kinases and for treatment of psoriasis
11/13/2007US7294628 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
11/13/2007US7294625 Pyrazole compounds
11/13/2007US7294621 Lipid analogs for combating tumors
11/13/2007US7294620 Lipid analogs for inhibiting HIV-1 activity
11/13/2007US7294618 Glucopyranosyloxypyrazole derivatives and medicinal use thereof
11/13/2007US7294615 Compounds that associate on the intermolecular level and aggregate bodies that contain them
11/13/2007US7294480 High throughput screening assays using fatty acid synthetic enzymes
11/13/2007US7294472 Method for identifying modulators of G protein coupled receptor signaling
11/13/2007US7294334 Methods and compositions to treat myocardial conditions
11/13/2007CA2480004C Process for production of steroid crystals, crystals obtained thereby and their use in pharmaceutical preparations
11/13/2007CA2442483C 3-heterocyclylpropanohydroxamic acid pcp inhibitors
11/13/2007CA2425557C Anticholinergic agents that can be used as medicaments and method for the production thereof
11/13/2007CA2423288C New pharmaceutical compositions containing epinastine and pseudoephedrine
11/13/2007CA2402707C Use of cdp-choline for the treatment of alcohol withdrawal syndrome
11/13/2007CA2383715C Improving condition of elderly pets
11/13/2007CA2345006C New benzoylguanidine derivatives with advantageous properties, processes for preparing them and their use in the production of pharmaceutical compositions
11/13/2007CA2318600C Apparatuses and processes for hyperthermia
11/13/2007CA2285574C Method and composition for treating sleep apnea
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/13/2007CA2157859C Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
11/13/2007CA2157856C Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
11/08/2007WO2007126128A1 Dihydropyrazolopyrimidinone derivative
11/08/2007WO2007126126A1 Novel aminopyridine derivative having aurora-a-selective inhibitory activity
11/08/2007WO2007126122A1 Dihydropyrazolopyrimidinone derivatives
11/08/2007WO2007126117A1 Phenyl 5-thioglucoside compound
11/08/2007WO2007126111A1 PEPTIDE CAPABLE OF INHIBITING AMYLOID-β FIBROSIS
11/08/2007WO2007126060A1 Salt of 1,2-dihydropyridine compound
11/08/2007WO2007126041A1 Benzisoxazole compound
11/08/2007WO2007126020A1 Compound having activity of blocking nmda receptor channel, and pharmaceutical agent using the same
11/08/2007WO2007126017A1 Agent for suppressing arteriosclerosis
11/08/2007WO2007126001A1 Antitussive or expectorant pharmaceutical composition comprising loxoprofen
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007WO2007125946A1 Peptide
11/08/2007WO2007125913A1 Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof
11/08/2007WO2007125832A1 Singlet oxygen scavenger, anti-skin-aging agent, anti-wrinkle agent, anti-sagging agent, agent for improving moisture content in the skin, skin-whitening agent, melanin formation inhibitor, nitrogen monooxide scavenger and antioxidant, each utilizing helipyrone a
11/08/2007WO2007125720A1 Molecular chaperone expression inducer
11/08/2007WO2007125621A1 Novel use of gene whose expression is increased in hyperplastic pancreatic islet
11/08/2007WO2007125619A1 Novel compound having gpr54 agonistic activity
11/08/2007WO2007125310A2 Pharmaceutical combinations of pk inhibitors and other active agents
11/08/2007WO2007124734A2 Compounds a-r-x for the manufacture of pharmaceutical preparations
11/08/2007WO2006120360A3 Active composition for treatment or prevention of problems related to a disturbance of the biological clock
11/08/2007WO2002046458A9 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
11/08/2007US20070259944 Amides such as 5-(3-Nitrophenyl)-1,3-dihydro-indol-2-one, used as antiprogesterones, contraceptives, for hormone replacement therapy during menopause and as anticarcinogenic agents
11/08/2007US20070259912 Polymorphic forms of a GABAA agonist
11/08/2007US20070259894 Use of Atazanavir for Improving the Pharmacokinetics of Drugs Metabolized by Ugt1a1
11/08/2007US20070259887 Inhibitors of polyq-aggregation
11/08/2007US20070259884 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
11/08/2007US20070259882 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
11/08/2007US20070259880 dipeptidyl peptidase IV (DPP-IV) inhibitors, useful for the prophylaxis or treatment of non-insulin dependent diabetes and obesity
11/08/2007US20070259874 Phosphodiesterase Inhibitors
1 ... 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 ... 1564